1. Home
  2. XAIR vs NDRA Comparison

XAIR vs NDRA Comparison

Compare XAIR & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$0.37

Market Cap

5.4M

Sector

Health Care

ML Signal

HOLD

Logo ENDRA Life Sciences Inc.

NDRA

ENDRA Life Sciences Inc.

HOLD

Current Price

$4.77

Market Cap

5.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XAIR
NDRA
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4M
5.5M
IPO Year
2015
2016

Fundamental Metrics

Financial Performance
Metric
XAIR
NDRA
Price
$0.37
$4.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$10.00
$30.00
AVG Volume (30 Days)
204.8K
13.0K
Earning Date
06-16-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
62.09
84.32
EPS
N/A
N/A
Revenue
$3,705,000.00
N/A
Revenue This Year
$122.00
N/A
Revenue Next Year
$58.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
219.67
N/A
52 Week Low
$0.15
$2.96
52 Week High
$3.78
$11.91

Technical Indicators

Market Signals
Indicator
XAIR
NDRA
Relative Strength Index (RSI) 35.55 53.63
Support Level N/A $4.95
Resistance Level $0.59 $5.18
Average True Range (ATR) 0.04 0.43
MACD -0.00 0.01
Stochastic Oscillator 17.09 58.28

Price Performance

Historical Comparison
XAIR
NDRA

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

About NDRA ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Share on Social Networks: